RHÖN-KLINIKUM Aktiengesellschaft (ADR)
General ticker "RKAGY" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $1.1B (TTM average)
RHÖN-KLINIKUM Aktiengesellschaft (ADR) follows the US Stock Market performance with the rate: 32.0%.
Estimated limits based on current volatility of 0.0%: low 8.16$, high 8.16$
Factors to consider:
- Company pays dividends (annually): last record date 2026-05-29, amount 0.12$ (Y1.47%)
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [6.86$, 10.20$]
- 2026-12-31 to 2027-12-31 estimated range: [7.56$, 11.12$]
Financial Metrics affecting the RKAGY estimates:
- Positive: with PPE of 14.7 at the end of fiscal year the price was neutral
- Positive: 6.77 < Operating cash flow per share per price, % of 7.16
- Positive: -13.52 < Operating profit margin, % of 0.23
- Positive: 3.66 < Industry operating cash flow per share per price (median), % of 4.90
- Positive: -4.55 < Industry operating profit margin (median), % of -0.34
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: -18.95 < Investing cash flow per share per price, % of -14.66
- Positive: Inventory ratio change, % of -0.43 <= -0.37
- Negative: 0.33 < Interest expense per share per price, % of 0.33
- Negative: Industry earnings per price (median), % of 0 <= 0
Short-term RKAGY quotes
Long-term RKAGY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €1,463.98MM | €1,595.62MM | €1,859.32MM |
| Operating Expenses | €1,423.58MM | €1,547.47MM | €1,855.10MM |
| Operating Income | €40.40MM | €48.15MM | €4.22MM |
| Non-Operating Income | €7.33MM | €8.05MM | €38.96MM |
| Interest Expense | €3.70MM | €3.40MM | €2.89MM |
| Income(Loss) | €47.73MM | €56.20MM | €43.18MM |
| Taxes | €7.56MM | €11.00MM | €8.32MM |
| Net Income(Loss)* | €38.71MM | €43.35MM | €33.11MM |
| Stockholders Equity | €1,252.04MM | €1,295.93MM | €1,320.06MM |
| Inventory | €34.21MM | €37.46MM | €40.56MM |
| Assets | €1,770.52MM | €1,856.48MM | €1,818.40MM |
| Operating Cash Flow | €109.00MM | €127.60MM | €61.95MM |
| Capital expenditure | €62.80MM | €70.40MM | €95.19MM |
| Investing Cash Flow | €40.90MM | €-50.40MM | €-126.89MM |
| Financing Cash Flow | €-21.20MM | €-3.30MM | €-40.34MM |
| Earnings Per Share** | €0.29 | €0.34 | €0.25 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.